Matt Segall

From Crucible Network Research Projects
Revision as of 07:21, 10 August 2011 by afb21 (talk | contribs) (Created page with "Founder of Optibrium, previously at ArQule, Matt commissioned a Crucible team to develop new interactive approaches to drug design that exploited quantum mechanical modelling...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

Founder of Optibrium, previously at ArQule, Matt commissioned a Crucible team to develop new interactive approaches to drug design that exploited quantum mechanical modelling techniques to optimise drug discovery processes through in silico simulation of compounds before they were synthesised.

Retrieved from "https://wiki.cam.ac.uk/wiki/crucible/index.php?title=Matt_Segall&oldid=288"